2,550 results on '"Reingold A"'
Search Results
2. The impact of pneumococcal serotype replacement on the effectiveness of a national immunization program: a population-based active surveillance cohort study in New Zealand.
- Author
-
Anglemyer, Andrew, Ren, Xiaoyun, Gilkison, Charlotte, Kumbaroff, Zoe, Morgan, Julie, DuBray, Kara, Tiong, Audrey, Reingold, Arthur, and Walls, Tony
- Subjects
Antimicrobial resistance ,PCV ,Pneumococcal disease ,Serotype replacement - Abstract
BACKGROUND: In Aotearoa New Zealand (NZ) PCV7 was introduced in 2008, then PCV10 in 2011 and PCV13 in 2014. In 2017 PCV10 was re-introduced, replacing PCV13. In the present study, we investigate the resultant rapidly changing invasive pneumococcal disease (IPD) epidemiology. METHODS: We compare the IPD incidence rate ratio (IRR) in NZ (2022 versus 2020) with other countries, and describe the IPD epidemiology (including trends in overall IPD and serotype 19A, and antimicrobial resistance) within NZ. Additionally, we performed a genomic-epidemiology investigation identifying the most common 19A sequence types and associated risk factors. FINDINGS: Though IPD incidence rates have increased in the US and Australia (2021-22) after declines in 2020, in NZ the incidence rate is the highest since 2011 with a significantly higher IRR than US (p
- Published
- 2024
3. Oral minoxidil for late alopecia in cancer survivors
- Author
-
Kuo, Alyce Mei-Shiuan, Reingold, Rachel E., Ketosugbo, Kwami F., Pan, Alexander, Kraehenbuehl, Lukas, Dusza, Stephen, Gajria, Devika, Lake, Diana E., Bromberg, Jacqueline F., Traina, Tiffany A., Fornier, Monica N., Gucalp, Ayca, D’Alessandro, Brian M., Rotemberg, Veronica, Dauscher, Megan, Shapiro, Jerry, Goldfarb, Shari B., Markova, Alina, and Lacouture, Mario E.
- Published
- 2024
- Full Text
- View/download PDF
4. Anticipated and Experienced Stigma After Testing Positive for SARS-CoV-2: A Qualitative Study.
- Author
-
De Zuzuarregui, Mariah, Frank, Darren, Gomez-Aladino, Sarah, Muñoz, Ariel, Williamson, Sabrina, Wang, Emily, Hunter, Lauren, Packel, Laura, Reingold, Arthur, and Facente, Shelley
- Subjects
COVID-19 ,SARS-CoV-2 ,public health messaging ,qualitative research ,stigma ,Humans ,SARS-CoV-2 ,COVID-19 ,COVID-19 Testing ,Pandemics ,Social Stigma - Abstract
INTRODUCTION: Stigma has inhibited public health practitioners influence during the COVID-19 pandemic. We explore the experienced and anticipated stigma of people affiliated with a large university in the United States, using the Health Stigma and Discrimination Framework. METHODS: We conducted a qualitative secondary substudy of 20 people who tested SARS-CoV-2 positive and 10 who tested negative in the summer of 2020, selected from a study of 3,324 university students and employees. FINDINGS: No participants reported anticipated stigmatization prior to testing positive. However, eight of 20 participants recounted stigma marking (being marked by COVID-19 diagnosis or membership in a high-risk group) or manifestations of stigma after testing positive, including feelings of guilt or shame, and concerns about being judged as selfish or irresponsible. Three described being denied services or social interactions as a result of having had COVID-19, long after their infectiousness ended. Participants noted that clear public health messaging must be paired with detailed scientific information, rather than leaving people to resort to non-experts to understand the science. DISCUSSION: Public health messaging designed to mitigate spread of SARS-CoV-2 and protect the community may perpetuate stigma and exacerbate inequities. As a result, people may avoid testing or treatment, mistrust public health messaging, or even use risk-increasing behavior as coping mechanisms. IMPLICATIONS FOR PRACTICE: Intentional use of language that promotes equity and deters discrimination must be high priority for any COVID-19-related public health messaging. Partnership with community leaders to co-create programs and disseminate messaging is a critical strategy for reducing stigma, especially for historically mistreated groups.
- Published
- 2024
5. Look What You Made Me Do: Jewish Swifties and A Fundraiser for Gaza
- Author
-
Reingold, Matt
- Published
- 2024
- Full Text
- View/download PDF
6. Navigating Crisis Together: Canadian Jews, Israel, and October 7
- Author
-
Reingold, Matt and Reznik, Shira
- Published
- 2024
- Full Text
- View/download PDF
7. Meningococcal Disease in Persons With HIV Reported Through Active Surveillance in the United States, 2009-2019.
- Author
-
Rudmann, Keegan, Cooper, Gabrielle, Marjuki, Henju, Reingold, Arthur, Barnes, Meghan, Petit, Susan, Moore, Ashley, Harrison, Lee, Lynfield, Ruth, Khanlian, Sarah, Anderson, Bridget, Martin, Tasha, Schaffner, William, McNamara, Lucy, and Rubis, Amy
- Subjects
Neisseria meningitidis ,invasive meningococcal disease ,people with HIV - Abstract
Persons with HIV (PWH) are at increased risk for bacterial infections, and previous publications document an increased risk for invasive meningococcal disease (IMD) in particular. This analysis provides evidence that PWH face a 6-fold increase in risk for IMD based on Active Bacterial Core surveillance data collected during 2009-2019.
- Published
- 2024
8. Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study.
- Author
-
Sumner, Kelsey, Masalovich, Svetlana, OHalloran, Alissa, Holstein, Rachel, Reingold, Arthur, Kirley, Pam, Alden, Nisha, Herlihy, Rachel, Meek, James, Yousey-Hindes, Kimberly, Anderson, Evan, Openo, Kyle, Monroe, Maya, Leegwater, Lauren, Henderson, Justin, Lynfield, Ruth, McMahon, Melissa, McMullen, Chelsea, Angeles, Kathy, Spina, Nancy, Engesser, Kerianne, Bennett, Nancy, Felsen, Christina, Lung, Krista, Shiltz, Eli, Thomas, Ann, Talbot, H, Schaffner, William, Swain, Ashley, George, Andrea, Rolfes, Melissa, Reed, Carrie, and Garg, Shikha
- Subjects
Humans ,United States ,Influenza ,Human ,Influenza Vaccines ,Cross-Sectional Studies ,Influenza A Virus ,H3N2 Subtype ,Influenza A Virus ,H1N1 Subtype ,Influenza B virus ,Influenza A virus ,Hospitalization - Abstract
BACKGROUND: Influenza burden varies across seasons, partly due to differences in circulating influenza virus types or subtypes. Using data from the US population-based surveillance system, Influenza Hospitalization Surveillance Network (FluSurv-NET), we aimed to assess the severity of influenza-associated outcomes in individuals hospitalised with laboratory-confirmed influenza virus infections during the 2010-11 to 2018-19 influenza seasons. METHODS: To evaluate the association between influenza virus type or subtype causing the infection (influenza A H3N2, A H1N1pdm09, and B viruses) and in-hospital severity outcomes (intensive care unit [ICU] admission, use of mechanical ventilation or extracorporeal membrane oxygenation [ECMO], and death), we used FluSurv-NET to capture data for laboratory-confirmed influenza-associated hospitalisations from the 2010-11 to 2018-19 influenza seasons for individuals of all ages living in select counties in 13 US states. All individuals had to have an influenza virus test within 14 days before or during their hospital stay and an admission date between Oct 1 and April 30 of an influenza season. Exclusion criteria were individuals who did not have a complete chart review; cases from sites that contributed data for three or fewer seasons; hospital-onset cases; cases with unidentified influenza type; cases of multiple influenza virus type or subtype co-infection; or individuals younger than 6 months and ineligible for the influenza vaccine. Logistic regression models adjusted for influenza season, influenza vaccination status, age, and FluSurv-NET site compared odds of in-hospital severity by virus type or subtype. When missing, influenza A subtypes were imputed using chained equations of known subtypes by season. FINDINGS: Data for 122 941 individuals hospitalised with influenza were captured in FluSurv-NET from the 2010-11 to 2018-19 seasons; after exclusions were applied, 107 941 individuals remained and underwent influenza A virus imputation when missing A subtype (43·4%). After imputation, data for 104 969 remained and were included in the final analytic sample. Averaging across imputed datasets, 57·7% (weighted percentage) had influenza A H3N2, 24·6% had influenza A H1N1pdm09, and 17·7% had influenza B virus infections; 16·7% required ICU admission, 6·5% received mechanical ventilation or ECMO, and 3·0% died (95% CIs had a range of less than 0·1% and are not displayed). Individuals with A H1N1pdm09 had higher odds of in-hospital severe outcomes than those with A H3N2: adjusted odds ratios (ORs) for A H1N1pdm09 versus A H3N2 were 1·42 (95% CI 1·32-1·52) for ICU admission; 1·79 (1·60-2·00) for mechanical ventilation or ECMO use; and 1·25 (1·07-1·46) for death. The adjusted ORs for individuals infected with influenza B versus influenza A H3N2 were 1·06 (95% CI 1·01-1·12) for ICU admission, 1·14 (1·05-1·24) for mechanical ventilation or ECMO use, and 1·18 (1·07-1·31) for death. INTERPRETATION: Despite a higher burden of hospitalisations with influenza A H3N2, we found an increased likelihood of in-hospital severe outcomes in individuals hospitalised with influenza A H1N1pdm09 or influenza B virus. Thus, it is important for individuals to receive an annual influenza vaccine and for health-care providers to provide early antiviral treatment for patients with suspected influenza who are at increased risk of severe outcomes, not only when there is high influenza A H3N2 virus circulation but also when influenza A H1N1pdm09 and influenza B viruses are circulating. FUNDING: The US Centers for Disease Control and Prevention.
- Published
- 2023
9. Transcriptional reprogramming in the entomopathogenic fungus Metarhizium brunneum and its aphid host Myzus persicae during the switch between saprophytic and parasitic lifestyles
- Author
-
Victoria Reingold, Adi Faigenboim, Sabina Matveev, Sabrina Haviv, Eduard Belausov, Andreas Vilcinskas, and Dana Ment
- Subjects
Mycopathogen ,Host–pathogen interaction ,Transcriptomics ,Live imaging ,Fungal infection ,Early infection ,Biotechnology ,TP248.13-248.65 ,Genetics ,QH426-470 - Abstract
Abstract Background The fungus Metarhizium brunneum has evolved a remarkable ability to switch between different lifestyles. It develops as a saprophyte, an endophyte establishing mutualistic relationships with plants, or a parasite, enabling its use for the control of insect pests such as the aphid Myzus persicae. We tested our hypothesis that switches between lifestyles must be accompanied by fundamental transcriptional reprogramming, reflecting adaptations to different environmental settings. Results We combined high throughput RNA sequencing of M. brunneum in vitro and at different stages of pathogenesis to validate the modulation of genes in the fungus and its host during the course of infection. In agreement with our hypothesis, we observed transcriptional reprogramming in M. brunneum following conidial attachment, germination on the cuticle, and early-stage growth within the host. This involved the upregulation of genes encoding degrading enzymes and gene clusters involved in synthesis of secondary metabolites that act as virulence factors. The transcriptional response of the aphid host included the upregulation of genes potentially involved in antifungal activity, but antifungal peptides were not induced. We also observed the induction of a host flightin gene, which may be involved in wing formation and flight muscle development. Conclusions The switch from saprophytic to parasitic development in M. brunneum is accompanied by fundamental transcriptional reprogramming during the course of the infection. The aphid host responds to fungal infection with its own transcriptional reprogramming, reflecting its inability to express antifungal peptides but featuring the induction of genes involved in winged morphs that may enable offspring to avoid the contaminated environment.
- Published
- 2024
- Full Text
- View/download PDF
10. Arts-Based Learning in Israel Education: A Qualitative Inquiry into Using Political Cartoons to Study Current Events in Israeli Society
- Author
-
Matt Reingold
- Abstract
An arts-based qualitative research study was conducted to study the use of political cartoons in Israel education in a high school class. Data analysis revealed that students' initial interest in the cartoons coupled with the diversity of representations of Israeli society on display in the cartoons facilitated an Israel education experience that afforded students the opportunity to engage in meaningful text-to-self connections that also deepened their understanding of the complexity of Israeli society.
- Published
- 2024
- Full Text
- View/download PDF
11. Attachment Representations of Female Child Sexual Abuse Survivors Reflected in the Bird's Nest Drawing Assessment
- Author
-
Limor Goldner and Ortal Herzig Reingold
- Abstract
The study examined the Bird's Nest Drawing (BND) of 14 adults who experienced child sexual abuse perpetrated by females, primarily their mothers. Descriptive analysis revealed the prevalence of insecure attachment and mainly an ambivalent representation. The drawings reflected vulnerability and under-protectiveness. Almost one-third of the drawings did not include caregiving and were suggestive of loneliness, abandonment, and rejection. When maternal caregiving was depicted, it was intrusive and characterized by a lack of separation, abandonment, or unsatisfying caregiving. The survivors' narratives (n = 4) revealed themes of sadness, lack of protection, and vulnerability related to their mothers' lack of competence. These findings suggest that the BND can serve as a valuable art therapy assessment tool to better understand attachment representations.
- Published
- 2024
- Full Text
- View/download PDF
12. COVID-19-Associated Hospitalizations Among U.S. Adults Aged ≥65 Years - COVID-NET, 13 States, January-August 2023.
- Author
-
Taylor, Christopher, Patel, Kadam, Patton, Monica, Kawasaki, Breanna, Meek, James, Openo, Kyle, Ryan, Patricia, Falkowski, Anna, Bye, Erica, Plymesser, Kelly, Spina, Nancy, Tesini, Brenda, Moran, Nancy, Sutton, Melissa, Talbot, H, George, Andrea, Havers, Fiona, and Reingold, Arthur
- Subjects
Humans ,Adult ,United States ,COVID-19 ,SARS-CoV-2 ,Hospitalization ,Intensive Care Units ,Vaccination - Abstract
Adults aged ≥65 years remain at elevated risk for severe COVID-19 disease and have higher COVID-19-associated hospitalization rates compared with those in younger age groups. Data from the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to estimate COVID-19-associated hospitalization rates during January-August 2023 and identify demographic and clinical characteristics of hospitalized patients aged ≥65 years during January-June 2023. Among adults aged ≥65 years, hospitalization rates more than doubled, from 6.8 per 100,000 during the week ending July 15 to 16.4 per 100,000 during the week ending August 26, 2023. Across all age groups, adults aged ≥65 years accounted for 62.9% (95% CI = 60.1%-65.7%) of COVID-19-associated hospitalizations, 61.3% (95% CI = 54.7%-67.6%) of intensive care unit admissions, and 87.9% (95% CI = 80.5%-93.2%) of in-hospital deaths associated with COVID-19 hospitalizations. Most hospitalized adults aged ≥65 years (90.3%; 95% CI = 87.2%-92.8%) had multiple underlying conditions, and fewer than one quarter (23.5%; 95% CI = 19.5%-27.7%) had received the recommended COVID-19 bivalent vaccine. Because adults aged ≥65 years remain at increased risk for COVID-19-associated hospitalization and severe outcomes, guidance for this age group should continue to focus on measures to prevent SARS-CoV-2 infection, encourage vaccination, and promote early treatment for persons who receive a positive SARS-CoV-2 test result to reduce their risk for severe COVID-19-associated outcomes.
- Published
- 2023
13. Transcriptional reprogramming in the entomopathogenic fungus Metarhizium brunneum and its aphid host Myzus persicae during the switch between saprophytic and parasitic lifestyles
- Author
-
Reingold, Victoria, Faigenboim, Adi, Matveev, Sabina, Haviv, Sabrina, Belausov, Eduard, Vilcinskas, Andreas, and Ment, Dana
- Published
- 2024
- Full Text
- View/download PDF
14. Factors associated with depressive symptoms among returnee migrants and non-migrants working adults in Madi municipality in Nepal: a community-based cross-sectional study
- Author
-
Adhikary, Pratik, Devkota, Hridaya Raj, Reingold, Arthur L., and Ghimire, Dirgha J.
- Published
- 2024
- Full Text
- View/download PDF
15. Bauer, Heike, Andrea Greenbaum, and Sarah Lightman, Eds. Jewish Women in Comics: Bodies and Borders: Syracuse University Press, 2023, 290 pages, 76 color illustrations
- Author
-
Reingold, Matt
- Published
- 2024
- Full Text
- View/download PDF
16. Epidemiology of Invasive Nontypeable Haemophilus influenzae Disease-United States, 2008-2019.
- Author
-
Oliver, Sara, Rubis, Amy, Soeters, Heidi, Reingold, Arthur, Barnes, Meghan, Petit, Susan, Farley, Monica, Harrison, Lee, Como-Sabetti, Kathy, Khanlian, Sarah, Wester, Rachel, Thomas, Ann, Schaffner, William, Marjuki, Henju, Wang, Xin, and Hariri, Susan
- Subjects
Haemophilus influenzae ,Haemophilus influenzae vaccines ,epidemiology ,nontypeable Haemophilus influenzae ,Infant ,Child ,Infant ,Newborn ,Humans ,Female ,Pregnancy ,United States ,Aged ,Haemophilus influenzae ,Haemophilus Infections ,Serotyping ,Incidence ,Postpartum Period ,Infant ,Newborn ,Diseases - Abstract
BACKGROUND: Nontypeable Haemophilus influenzae (NTHi) is the most common cause of invasive H. influenzae disease in the United States (US). We evaluated the epidemiology of invasive NTHi disease in the US, including among pregnant women, infants, and people with human immunodeficiency virus (PWH). METHODS: We used data from population- and laboratory-based surveillance for invasive H. influenzae disease conducted in 10 sites to estimate national incidence of NTHi, and to describe epidemiology in women of childbearing age, infants aged ≤30 days (neonates), and PWH living in the surveillance catchment areas. H. influenzae isolates were sent to the Centers for Disease Control and Prevention for species confirmation, serotyping, and whole genome sequencing of select isolates. RESULTS: During 2008-2019, average annual NTHi incidence in the US was 1.3/100 000 population overall, 5.8/100 000 among children aged
- Published
- 2023
17. Shortage of essential pediatric medications puts children's health at risk. Results from a European Confederation of Primary Care Paediatricians (ECPCP) Survey 2023
- Author
-
Christine Magendie, Gottfried Huss, Laura Reali, and Stephen Reingold
- Subjects
Medicine shortages ,Paediatric primary care ,Public health ,Pediatrics ,RJ1-570 - Abstract
Unparalleled drug shortages during the winter of 2022/2023 had a profound impact on paediatric primary care across Europe. A survey conducted by the European Confederation of Primary Care Paediatricians (ECPCP) evaluated the availability of essential pediatric drugs and the resulting challenges. The survey was conducted between January and March 2023 and included responses from 640 paediatricians from 18 countries. The results of the survey indicated that there were substantial shortages, particularly of child friendly formulations of commonly prescribed medicines. Paediatricians in the survey feared that the use of less appropriate alternatives could potentially compromise the efficacy and safety of treatment. The survey findings highlight the urgent need for coordinated actions at multiple levels to ensure the availability of essential pediatric medications and safeguard children's health in future crises.
- Published
- 2024
- Full Text
- View/download PDF
18. 'Easier to Understand but More Difficult to Digest': Student Experiences with Israeli Yom HaZikaron Cartoons
- Author
-
Matt Reingold
- Subjects
Language and Literature ,Judaism ,BM1-990 ,Sociology (General) ,HM401-1281 - Abstract
Yom HaZikaron, Israel’s Remembrance Day, has received considerable scholarly attention, with research published about how the country’s youth understand the day but there has been no comparable data from diaspora Jews. This article presents findings about how a cohort of Canadian Jewish teenagers participating in a gallery walk of Israeli political cartoons provided new ways of thinking about and relating to Yom HaZikaron. The data revealed that students care about Yom HaZikaron but struggle to form a connection to the day. Political cartoons that depicted personal loss led students to form new insights into the day and to new associations and connections with Israelis.
- Published
- 2024
19. Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020.
- Author
-
Prasad, Namrata, Rhodes, Julia, Deng, Li, McCarthy, Natalie, Moline, Heidi, Baggs, James, Reddy, Sujan, Jernigan, John, Havers, Fiona, Sosin, Daniel, Thomas, Ann, Lynfield, Ruth, Schaffner, William, Reingold, Arthur, Burzlaff, Kari, Harrison, Lee, Petit, Susan, Farley, Monica, Herlihy, Rachel, Nanduri, Srinivas, Pilishvili, Tamara, McNamara, Lucy, Schrag, Stephanie, Fleming-Dutra, Katherine, Kobayashi, Miwako, and Arvay, Melissa
- Subjects
COVID-19 ,United States ,invasive bacterial disease ,nonpharmaceutical intervention ,United States ,Humans ,Infant ,Incidence ,Pandemics ,COVID-19 ,Bacterial Infections ,Streptococcus pneumoniae ,Haemophilus influenzae ,Streptococcus agalactiae - Abstract
BACKGROUND: Descriptions of changes in invasive bacterial disease (IBD) epidemiology during the coronavirus disease 2019 (COVID-19) pandemic in the United States are limited. METHODS: We investigated changes in the incidence of IBD due to Streptococcus pneumoniae, Haemophilus influenzae, group A Streptococcus (GAS), and group B Streptococcus (GBS). We defined the COVID-19 pandemic period as 1 March to 31 December 2020. We compared observed IBD incidences during the pandemic to expected incidences, consistent with January 2014 to February 2020 trends. We conducted secondary analysis of a health care database to assess changes in testing by blood and cerebrospinal fluid (CSF) culture during the pandemic. RESULTS: Compared with expected incidences, the observed incidences of IBD due to S. pneumoniae, H. influenzae, GAS, and GBS were 58%, 60%, 28%, and 12% lower during the pandemic period of 2020, respectively. Declines from expected incidences corresponded closely with implementation of COVID-19-associated nonpharmaceutical interventions (NPIs). Significant declines were observed across all age and race groups, and surveillance sites for S. pneumoniae and H. influenzae. Blood and CSF culture testing rates during the pandemic were comparable to previous years. CONCLUSIONS: NPIs likely contributed to the decline in IBD incidence in the United States in 2020; observed declines were unlikely to be driven by reductions in testing.
- Published
- 2023
20. Monitoring SARS-CoV-2 incidence and seroconversion among university students and employees: a longitudinal cohort study in California, June–August 2020
- Author
-
Hunter, Lauren A, Wyman, Stacia, Packel, Laura J, Facente, Shelley N, Li, Yi, Harte, Anna, Nicolette, Guy, Consortium, the IGI SARS-CoV-2 Testing, Di Germanio, Clara, Busch, Michael P, Reingold, Arthur L, Petersen, Maya L, Urnov, Fyodor, McDevitt, Shana, Hirsch, Ariana, Ehrenberg, Alexander, Doudna, Jennifer A, Amen, M, Barry, Kerrie W, Boyle, John M, Brook, Cara E, Choo, Seunga, Cornmesser, Dilworth, David J, Fedrigo, Indro, Friedline, Skyler E, Graham, Thomas GW, Green, Ralph, Hamilton, Jennifer R, Hochstrasser, Megan L, Hockemeyer, Dirk, Krishnappa, Netravathi, Lari, Azra, Li, Hanqin, Lin-Shiao, Enrique, Lu, Tianlin, Lyons, Elijah F, Mark, Kevin G, Martell, Lisa Argento, Martins, A Raquel O, Mitchell, Patrick S, Moehle, Erica A, Naca, Christine, Nandakumar, Divya, O’Brien, Elizabeth, Pappas, Derek J, Pestal, Kathleen, Quach, Diana L, Rubin, Benjamin E, Sachdeva, Rohan, Stahl, Elizabeth C, Syed, Abdullah Muhammad, Tan, I-Li, Tollner, Amy L, Tsuchida, Connor A, Tsui, C Kimberly, Turkalo, Timothy K, Warf, M Bryan, Whitney, Oscar N, and Witkowsky, Lea B
- Subjects
Biodefense ,Emerging Infectious Diseases ,Infectious Diseases ,Vaccine Related ,Prevention ,Clinical Research ,Infection ,Good Health and Well Being ,Humans ,SARS-CoV-2 ,COVID-19 ,Incidence ,COVID-19 Testing ,Longitudinal Studies ,Universities ,Seroconversion ,Phylogeny ,Prospective Studies ,California ,Cohort Studies ,EPIDEMIOLOGY ,Public health ,Infection control ,Epidemiology ,PUBLIC HEALTH ,IGI SARS-CoV-2 Testing Consortium ,Clinical Sciences ,Public Health and Health Services ,Other Medical and Health Sciences - Abstract
ObjectivesTo identify incident SARS-CoV-2 infections and inform effective mitigation strategies in university settings, we piloted an integrated symptom and exposure monitoring and testing system among a cohort of university students and employees.DesignProspective cohort study.SettingA public university in California from June to August 2020.Participants2180 university students and 738 university employees.Primary outcome measuresAt baseline and endline, we tested participants for active SARS-CoV-2 infection via quantitative PCR (qPCR) test and collected blood samples for antibody testing. Participants received notifications to complete additional qPCR tests throughout the study if they reported symptoms or exposures in daily surveys or were selected for surveillance testing. Viral whole genome sequencing was performed on positive qPCR samples, and phylogenetic trees were constructed with these genomes and external genomes.ResultsOver the study period, 57 students (2.6%) and 3 employees (0.4%) were diagnosed with SARS-CoV-2 infection via qPCR test. Phylogenetic analyses revealed that a super-spreader event among undergraduates in congregate housing accounted for at least 48% of cases among study participants but did not spread beyond campus. Test positivity was higher among participants who self-reported symptoms (incidence rate ratio (IRR) 12.7; 95% CI 7.4 to 21.8) or had household exposures (IRR 10.3; 95% CI 4.8 to 22.0) that triggered notifications to test. Most (91%) participants with newly identified antibodies at endline had been diagnosed with incident infection via qPCR test during the study.ConclusionsOur findings suggest that integrated monitoring systems can successfully identify and link at-risk students to SARS-CoV-2 testing. As the study took place before the evolution of highly transmissible variants and widespread availability of vaccines and rapid antigen tests, further research is necessary to adapt and evaluate similar systems in the present context.
- Published
- 2023
21. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022.
- Author
-
Armistead, Isaac, Meek, James, Anderson, Evan, Weigel, Andy, Reeg, Libby, Como-Sabetti, Kathryn, Ropp, Susan, Muse, Alison, Bushey, Sophrena, Shiltz, Eli, Sutton, Melissa, Talbot, H, Chatelain, Ryan, Havers, Fiona, Shah, Melisa, Patel, Kadam, Milucky, Jennifer, Taylor, Christopher, and Reingold, Arthur
- Subjects
COVID‐19 ,COVID‐NET ,SARS‐CoV‐2 ,bacterial coinfection ,viral coinfection ,Adult ,Humans ,Coinfection ,COVID-19 ,Influenza ,Human ,SARS-CoV-2 ,Virus Diseases ,Bacterial Infections - Abstract
BACKGROUND: Bacterial and viral infections can occur with SARS-CoV-2 infection, but prevalence, risk factors, and associated clinical outcomes are not fully understood. METHODS: We used the Coronavirus Disease 2019-Associated Hospitalization Surveillance Network (COVID-NET), a population-based surveillance system, to investigate the occurrence of bacterial and viral infections among hospitalized adults with laboratory-confirmed SARS-CoV-2 infection between March 2020 and April 2022. Clinician-driven testing for bacterial pathogens from sputum, deep respiratory, and sterile sites were included. The demographic and clinical features of those with and without bacterial infections were compared. We also describe the prevalence of viral pathogens including respiratory syncytial virus, rhinovirus/enterovirus, influenza, adenovirus, human metapneumovirus, parainfluenza viruses, and non-SARS-CoV-2 endemic coronaviruses. RESULTS: Among 36 490 hospitalized adults with COVID-19, 53.3% had bacterial cultures taken within 7 days of admission and 6.0% of these had a clinically relevant bacterial pathogen. After adjustment for demographic factors and co-morbidities, bacterial infections in patients with COVID-19 within 7 days of admission were associated with an adjusted relative risk of death 2.3 times that of patients with negative bacterial testing. Staphylococcus aureus and Gram-negative rods were the most frequently isolated bacterial pathogens. Among hospitalized adults with COVID-19, 2766 (7.6%) were tested for seven virus groups. A non-SARS-CoV-2 virus was identified in 0.9% of tested patients. CONCLUSIONS: Among patients with clinician-driven testing, 6.0% of adults hospitalized with COVID-19 were identified to have bacterial coinfections and 0.9% were identified to have viral coinfections; identification of a bacterial coinfection within 7 days of admission was associated with increased mortality.
- Published
- 2023
22. Acute Cardiac Events During COVID-19-Associated Hospitalizations.
- Author
-
Woodruff, Rebecca, Garg, Shikha, George, Mary, Patel, Kadam, Jackson, Sandra, Loustalot, Fleetwood, Wortham, Jonathan, Taylor, Christopher, Whitaker, Michael, Alden, Nisha, Meek, James, Anderson, Evan, Weigel, Andy, Henderson, Justin, Bye, Erica, Davis, Sarah, Barney, Grant, Bennett, Nancy, Shiltz, Eli, Sutton, Melissa, Talbot, H, Price, Andrea, Sperling, Laurence, Havers, Fiona, and Reingold, Arthur
- Subjects
COVID-19 ,SARS-CoV-2 ,United States ,adults ,heart diseases ,hospitalization ,Adult ,Humans ,COVID-19 ,SARS-CoV-2 ,Hospital Mortality ,Hospitalization ,Heart Diseases - Abstract
BACKGROUND: COVID-19 is associated with cardiac complications. OBJECTIVES: The purpose of this study was to estimate the prevalence, risk factors, and outcomes associated with acute cardiac events during COVID-19-associated hospitalizations among adults. METHODS: During January 2021 to November 2021, medical chart abstraction was conducted on a probability sample of adults hospitalized with laboratory-confirmed SARS-CoV-2 infection identified from 99 U.S. counties in 14 U.S. states in the COVID-19-Associated Hospitalization Surveillance Network. We calculated the prevalence of acute cardiac events (identified by International Classification of Diseases-10th Revision-Clinical Modification codes) by history of underlying cardiac disease and examined associated risk factors and disease outcomes. RESULTS: Among 8,460 adults, 11.4% (95% CI: 10.1%-12.9%) experienced an acute cardiac event during a COVID-19-associated hospitalization. Prevalence was higher among adults who had underlying cardiac disease (23.4%; 95% CI: 20.7%-26.3%) compared with those who did not (6.2%; 95% CI: 5.1%-7.6%). Acute ischemic heart disease (5.5%; 95% CI: 4.5%-6.5%) and acute heart failure (5.4%; 95% CI: 4.4%-6.6%) were the most prevalent events; 0.3% (95% CI: 0.1%-0.5%) experienced acute myocarditis or pericarditis. Risk factors varied by underlying cardiac disease status. Patients with ≥1 acute cardiac event had greater risk of intensive care unit admission (adjusted risk ratio: 1.9; 95% CI: 1.8-2.1) and in-hospital death (adjusted risk ratio: 1.7; 95% CI: 1.3-2.1) compared with those who did not. CONCLUSIONS: Acute cardiac events were common during COVID-19-associated hospitalizations, particularly among patients with underlying cardiac disease, and are associated with severe disease outcomes. Persons at greater risk for experiencing acute cardiac events during COVID-19-associated hospitalizations might benefit from more intensive clinical evaluation and monitoring during hospitalization.
- Published
- 2023
23. Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).
- Author
-
Delahoy, Miranda, Ujamaa, Dawud, Taylor, Christopher, Cummings, Charisse, Anglin, Onika, Holstein, Rachel, Milucky, Jennifer, OHalloran, Alissa, Patel, Kadam, Pham, Huong, Whitaker, Michael, Chai, Shua, Alden, Nisha, Kawasaki, Breanna, Meek, James, Yousey-Hindes, Kimberly, Anderson, Evan, Openo, Kyle, Weigel, Andy, Teno, Kenzie, Reeg, Libby, Leegwater, Lauren, Lynfield, Ruth, McMahon, Melissa, Ropp, Susan, Rudin, Dominic, Muse, Alison, Spina, Nancy, Bennett, Nancy, Popham, Kevin, Billing, Laurie, Shiltz, Eli, Sutton, Melissa, Thomas, Ann, Schaffner, William, Talbot, H, Crossland, Melanie, McCaffrey, Keegan, Hall, Aron, Burns, Erin, McMorrow, Meredith, Reed, Carrie, Havers, Fiona, Garg, Shikha, and Reingold, Arthur
- Subjects
COVID-19 ,SARS-CoV-2 ,children ,influenza ,surveillance ,Adolescent ,Child ,Humans ,United States ,Aged ,Aged ,80 and over ,Influenza ,Human ,COVID-19 ,Pandemics ,SARS-CoV-2 ,Hospitalization - Abstract
BACKGROUND: Influenza virus and SARS-CoV-2 are significant causes of respiratory illness in children. METHODS: Influenza- and COVID-19-associated hospitalizations among children
- Published
- 2023
24. Association between epidemiologic case definition categories and adverse clinical outcome in patients with Clostridiodes difficile infection in San Francisco County, California: a five-year retrospective cohort study.
- Author
-
Siraw, Bekure, Meyahnwi, Didien, and Reingold, Arthur
- Subjects
Adverse outcome ,Case definition category ,Clostridiodes difficile ,Mortality ,Recurrence ,Humans ,Community-Acquired Infections ,Retrospective Studies ,Clostridioides difficile ,Clostridium Infections ,San Francisco ,Cross Infection ,Risk Factors - Abstract
BACKGROUND: Understanding the predictors of adverse clinical outcomes following incident Clostridiodes difficile infection (CDI) can help clinicians identify which patients are at risk of complications and help prioritize the provision of their care. In this study, we assessed the associations between epidemiologic case definition categories and adverse clinical outcomes in patients with CDI in San Francisco County, California. METHODS: We conducted a retrospective cohort study using CDI surveillance data (n = 3274) from the California Emerging Infections Program for the time period 2016 to 2020. After independent associations were established, two multivariable logistic and log-binomial regression models were constructed for the final statistical analysis. RESULT: The mean cumulative incidence of CDI cases was 78.8 cases per 100,000 population. The overall recurrence rate and the 30-day all-cause mortality rate were 11.1% and 4.5%, respectively. After adjusting for potential confounders, compared to the community associated CDI cases, healthcare facility onset (AOR = 3.1; 95% CI [1.3-7]) and community-onset-healthcare facility associated (AOR = 2.4; 95% CI [1.4-4.3]) CDI cases were found to have higher odds of all-cause 30-day mortality. Community onset-healthcare facility-associated CDI case definition category was found to be significantly associated with an increased risk of recurrence of CDI (ARR = 1.7; 95% CI [1.2-2.4]). CONCLUSION: Although the incidence of community-associated CDI cases has been rising, the odds of all-cause 30-day mortality and the risk of recurrent CDI associated with these infections are lower than healthcare facility onset and community-onset healthcare facility-associated CDI cases.
- Published
- 2023
25. Factors associated with depressive symptoms among returnee migrants and non-migrants working adults in Madi municipality in Nepal: a community-based cross-sectional study
- Author
-
Pratik Adhikary, Hridaya Raj Devkota, Arthur L. Reingold, and Dirgha J. Ghimire
- Subjects
Mental health ,Working population ,Labour ,Migration ,Depressive symptoms ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Mental health is a growing concern worldwide. It is not well understood whether international labour migrants from Nepal who return to Nepal are at higher risk of developing mental health problems. The purpose of our study was to determine the prevalence of and examine the associated factors for depressive symptoms among returnee migrants and non-migrant working male adults in Nepal. Methods A cross-sectional survey of a probability-based sample of 725 participants was conducted in February 2020. The sample was comprised of two groups based on migration status: returning migrants and non-migrants. The 21-item Beck Depression Inventory (BDI-21) questionnaire was used to assess depressive symptoms. Logistic regression was applied to investigate factors associated with symptoms of depression. Results The overall prevalence of depressive symptoms was 10.1%. However, the prevalence of depressive symptoms was lower (7%) among returnee migrants compared to non-migrants (13.7%). Men in the lower income group had a higher chance of having depressive (AOR = 5.88, 95% CI: 2.17–15.96) than those in the higher income group. Similarly, Buddhists and Christians were more likely to be depressed (AOR = 2.20, 95% CI: 1.03–4.68) than Hindus. Participants with more than two children had a higher chance of having of depressive symptoms (AOR = 4.80, 95% CI: 1.15–20.05) compared with those without children. Unmarried men were more likely to be depressed (AOR = 4.07, 95%, CI:1.11–14.92) than those who were married. Conclusion The working Nepali adult male population in Nepal, including returning migrants, is at risk of depressive symptoms, but this association was lower in those in the higher income group, returnee migrants, those who were married, Hindus and those with no children. Our results highlight the need to monitor and develop national policies to ensure the mental health of the Nepali male adult population, including returnee migrants.
- Published
- 2024
- Full Text
- View/download PDF
26. Water and war: The effect of functioning chlorinated water stations in reducing waterborne diseases during conflict in northwest Syria, 2017-2021.
- Author
-
Haar, Rohini, Abdelrahman, Sarah, Muzzall, Evan, Aladhan, Ibrahim, Shobak, Kasim, Kawas, Mohamad, Aksh, Aya, Reingold, Arthur, AlMhawish, Naser, and Blair, Alden
- Abstract
Since 2011, Syria has been engulfed in a complex conflict marked by both targeted and indiscriminate attacks on civilians and civilian infrastructure. Water infrastructure has been continuously targeted, exacerbating problems with contamination of and access to clean adequate drinking water, and increasing the risk of waterborne diseases. We aimed to determine whether having access to more functional and chlorinated water stations is associated with a reduced risk of waterborne disease in northwest Syria. We examined the effect of functioning chlorinated water stations on the incidence of waterborne disease in 10 districts of Northwest Syria between January 1, 2017, and June 30, 2021, using weekly reported disease surveillance data and data from a water, sanitation, and hygiene (WASH) system evaluation program of the Assistance Coordination Unit (ACU). We ran eight negative binomial models to examine the association between functioning chlorinated water stations and the incidence of four of the five waterborne diseases: acute bloody diarrhea (ABD), acute other diarrhea (AOD), acute jaundice syndrome (AJS), and severe typhoid fever (STF). Dose-response models were used to investigate how the incidence of disease can theoretically be reduced as functioning and chlorinated water stations strategically increase. Compared to areas with lower quintiles of functioning and chlorinated water stations, the rates of the four waterborne diseases were lower in areas with higher quintiles of functioning and chlorinated water stations. Exposure to functioning water stations had a stronger association with lower rates of waterborne diseases than exposure to chlorinated water stations. Dose-response models demonstrate a potential for curbing the incidence of acute diarrhea and acute jaundice syndrome. The results of this study provide an understanding of the effects of water station functionality and chlorination in conflict settings. These findings support greater prioritization of WASH activities in countries experiencing violence against civilian infrastructure.
- Published
- 2023
27. Secondary Cases of Invasive Disease Caused by Encapsulated and Nontypeable Haemophilus influenzae — 10 U.S. Jurisdictions, 2011–2018
- Author
-
Oliver, Sara E, Rubis, Amy B, Soeters, Heidi M, Reingold, Arthur, Barnes, Meghan, Petit, Susan, Moore, Ashley E, Harrison, Lee H, Lynfield, Ruth, Angeles, Kathy M, Burzlaff, Kari E, Thomas, Ann, Schaffner, William, Marjuki, Henju, Wang, Xin, and Hariri, Susan
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Infectious Diseases ,Immunization ,Prevention ,Vaccine Related ,Clinical Research ,Pediatric ,Infection ,Good Health and Well Being ,Humans ,United States ,Infant ,Haemophilus influenzae ,Incidence ,Haemophilus Infections ,Serogroup ,Anti-Bacterial Agents ,Haemophilus Vaccines ,General & Internal Medicine - Abstract
Haemophilus influenzae (Hi) can cause meningitis and other serious invasive disease. Encapsulated Hi is classified into six serotypes (a-f) based on chemical composition of the polysaccharide capsule; unencapsulated strains are termed nontypeable Hi (NTHi). Hi serotype b (Hib) was the most common cause of bacterial meningitis in children in the pre-Hib vaccine era, and secondary transmission of Hi among children (e.g., to household contacts and in child care facilities) (1,2) led to the Advisory Committee on Immunization Practices (ACIP) recommendation for antibiotic chemoprophylaxis to prevent Hib disease in certain circumstances.* High Hib vaccination coverage since the 1990s has substantially reduced Hib disease, and other serotypes now account for most Hi-associated invasive disease in the United States (3). Nevertheless, CDC does not currently recommend chemoprophylaxis for contacts of persons with invasive disease caused by serotypes other than Hib and by NTHi (non-b Hi). Given this changing epidemiology, U.S. surveillance data were reviewed to investigate secondary cases of invasive disease caused by Hi. The estimated prevalence of secondary transmission was 0.32% among persons with encapsulated Hi disease (≤60 days of one another) and 0.12% among persons with NTHi disease (≤14 days of one another). Isolates from all Hi case pairs were genetically closely related, and all patients with potential secondary infection had underlying medical conditions. These results strongly suggest that secondary transmission of non-b Hi occurs. Expansion of Hi chemoprophylaxis recommendations might be warranted to control invasive Hi disease in certain populations in the United States, but further analysis is needed to evaluate the potential benefits against the risks, such as increased antibiotic use.
- Published
- 2023
28. Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries
- Author
-
Perier, Celine, Nasinghe, Emmanuel, Charles, Isabelle, Ssetaba, Leoson Junior, Ahyong, Vida, Bangs, Derek, Beatty, P Robert, Czudnochowski, Nadine, Diallo, Amy, Dugan, Eli, Fabius, Jacqueline M, Baker, Hildy Fong, Gardner, Jackson, Isaacs, Stephen, Joanah, Birungi, Kalantar, Katrina, Kateete, David, Knight, Matt, Krasilnikov, Maria, Krogan, Nevan J, Langelier, Chaz, Lee, Eric, Li, Lucy M, Licht, Daniel, Lien, Katie, Lyons, Zilose, Mboowa, Gerald, Mwebaza, Ivan, Mwesigwa, Savannah, Nalwadda, Geraldine, Nichols, Robert, Penaranda, Maria Elena, Petnic, Sarah, Phelps, Maira, Popper, Stephen J, Rape, Michael, Reingold, Arthur, Robbins, Richard, Rosenberg, Oren S, Savage, David F, Schildhauer, Samuel, Settles, Matthew L, Sserwadda, Ivan, Stanley, Sarah, Tato, Cristina M, Tsitsiklis, Alexandra, Van Dis, Erik, Vanaerschot, Manu, Vinden, Joanna, Cox, Jeffery S, Joloba, Moses L, and Schaletzky, Julia
- Subjects
Infectious Diseases ,Good Health and Well Being ,Partnerships for the Goals ,Capacity Building ,Developing Countries ,Global Health ,Humans ,Poverty ,Students ,Universities ,Capacity strengthening ,Africa ,Uganda ,research ,infectious diseases ,Public Health and Health Services - Abstract
Science education and research have the potential to drive profound change in low- and middle-income countries (LMICs) through encouraging innovation, attracting industry, and creating job opportunities. However, in LMICs, research capacity is often limited, and acquisition of funding and access to state-of-the-art technologies is challenging. The Alliance for Global Health and Science (the Alliance) was founded as a partnership between the University of California, Berkeley (USA) and Makerere University (Uganda), with the goal of strengthening Makerere University's capacity for bioscience research. The flagship program of the Alliance partnership is the MU/UCB Biosciences Training Program, an in-country, hands-on workshop model that trains a large number of students from Makerere University in infectious disease and molecular biology research. This approach nucleates training of larger and more diverse groups of students, development of mentoring and bi-directional research partnerships, and support of the local economy. Here, we describe the project, its conception, implementation, challenges, and outcomes of bioscience research workshops. We aim to provide a blueprint for workshop implementation, and create a valuable resource for bioscience research capacity strengthening in LMICs.
- Published
- 2022
29. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season
- Author
-
Adams, Katherine, Tastad, Katie J, Huang, Stacy, Ujamaa, Dawud, Kniss, Krista, Cummings, Charisse, Reingold, Arthur, Roland, Jeremy, Austin, Elizabeth, Kawasaki, Breanna, Meek, James, Yousey-Hindes, Kimberly, Anderson, Evan J, Openo, Kyle P, Reeg, Libby, Leegwater, Lauren, McMahon, Melissa, Bye, Erica, Poblete, Mayvilynne, Landis, Zachary, Spina, Nancy L, Engesser, Kerianne, Bennett, Nancy M, Gaitan, Maria A, Shiltz, Eli, Moran, Nancy, Sutton, Melissa, Abdullah, Nasreen, Schaffner, William, Talbot, H Keipp, Olsen, Kristen, Staten, Holly, Taylor, Christopher A, Havers, Fiona P, Reed, Carrie, Budd, Alicia, Garg, Shikha, O’Halloran, Alissa, and Brammer, Lynnette
- Subjects
Influenza ,Pediatric ,Immunization ,Infectious Diseases ,Biodefense ,Emerging Infectious Diseases ,Vaccine Related ,Prevention ,Lung ,Pneumonia & Influenza ,Infection ,Good Health and Well Being ,Child ,Humans ,Adolescent ,United States ,SARS-CoV-2 ,Influenza ,Human ,Coinfection ,Seasons ,Prevalence ,COVID-19 ,Death ,General & Internal Medicine - Abstract
The 2022-23 influenza season shows an early rise in pediatric influenza-associated hospitalizations (1). SARS-CoV-2 viruses also continue to circulate (2). The current influenza season is the first with substantial co-circulation of influenza viruses and SARS-CoV-2 (3). Although both seasonal influenza viruses and SARS-CoV-2 can contribute to substantial pediatric morbidity (3-5), whether coinfection increases disease severity compared with that associated with infection with one virus alone is unknown. This report describes characteristics and prevalence of laboratory-confirmed influenza virus and SARS-CoV-2 coinfections among patients aged
- Published
- 2022
30. Epidemiologic features, clinical characteristics, and predictors of mortality in patients with candidemia in Alameda County, California; a 2017–2020 retrospective analysis
- Author
-
Meyahnwi, Didien, Siraw, Bekure B, and Reingold, Arthur
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Hematology ,Clinical Research ,Prevention ,Infectious Diseases ,Sepsis ,Good Health and Well Being ,Humans ,Aged ,Candidemia ,Retrospective Studies ,Candida ,Candida albicans ,Risk Factors ,California ,Antifungal Agents ,Bloodstream infections ,Emerging infections ,Invasive candidiasis ,Microbiology ,Medical Microbiology ,Clinical sciences ,Medical microbiology ,Public health - Abstract
BackgroundBloodstream infections caused by Candida species are responsible for significant morbidity and mortality worldwide, with an ever-changing epidemiology. We conducted this study to assess trends in the epidemiologic features, risk factors and Candida species distribution in candidemia patients in Alameda County, California.MethodsWe analyzed data collected from patients in Alameda County, California between 2017 and 2020 as part of the California Emerging Infections Program (CEIP). This is a laboratory-based, active surveillance program for candidemia. In our study, we included incident cases only.ResultsDuring the 4-year period from January 1st, 2017, to December 31st, 2020, 392 incident cases of candidemia were identified. The mean crude annual cumulative incidence was 5.9 cases per 100,000 inhabitants (range 5.0-6.5 cases per 100,000 population). Candida glabrata was the most common Candida species and was present as the only Candida species in 149 cases (38.0%), followed by Candida albicans, 130 (33.2%). Mixed Candida species were present in 13 patients (3.3%). Most of the cases of candidemia occurred in individuals with one or more underlying conditions. Multivariate regression models showed that age ≥ 65 years (RR 1.66, CI 1.28-2.14), prior administration of systemic antibiotic therapy, (RR 1.84, CI 1.06-3.17), cirrhosis of the liver, (RR 2.01, CI 1.51-2.68), and prior admission to the ICU (RR1.82, CI 1.36-2.43) were significant predictors of mortality.ConclusionsNon-albicans Candida species currently account for the majority of candidemia cases in Alameda County.
- Published
- 2022
31. Conference Report – Recommendations from the Forum for Collaborative Research Symposium on hepatitis B elimination and universal hepatitis B adult vaccination in the United States
- Author
-
Mitchell Leus, Mayland Treat, Veronica Miller, and Arthur Reingold
- Subjects
Hepatitis B virus ,Universal adult vaccination ,ImplementationB elimination ,Microbiology ,QR1-502 ,Public aspects of medicine ,RA1-1270 - Published
- 2024
- Full Text
- View/download PDF
32. The impact of pneumococcal serotype replacement on the effectiveness of a national immunization program: a population-based active surveillance cohort study in New ZealandResearch in context
- Author
-
Andrew Anglemyer, Xiaoyun Ren, Charlotte Gilkison, Zoe Kumbaroff, Julie Morgan, Kara DuBray, Audrey Tiong, Arthur Reingold, and Tony Walls
- Subjects
Pneumococcal disease ,Serotype replacement ,PCV ,Antimicrobial resistance ,Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: In Aotearoa New Zealand (NZ) PCV7 was introduced in 2008, then PCV10 in 2011 and PCV13 in 2014. In 2017 PCV10 was re-introduced, replacing PCV13. In the present study, we investigate the resultant rapidly changing invasive pneumococcal disease (IPD) epidemiology. Methods: We compare the IPD incidence rate ratio (IRR) in NZ (2022 versus 2020) with other countries, and describe the IPD epidemiology (including trends in overall IPD and serotype 19A, and antimicrobial resistance) within NZ. Additionally, we performed a genomic-epidemiology investigation identifying the most common 19A sequence types and associated risk factors. Findings: Though IPD incidence rates have increased in the US and Australia (2021–22) after declines in 2020, in NZ the incidence rate is the highest since 2011 with a significantly higher IRR than US (p
- Published
- 2024
- Full Text
- View/download PDF
33. The Ideological Perspective of School Principals' Perceptions-Educational Leaders Defining Their Roles
- Author
-
Dery, Keren and Reingold, Roni
- Abstract
This research describes the perceptions of school principals in the context of their role in leading the professional development of the teaching staff. Their perceptions were examined in reference to three educational ideologies: socialization, acculturation and individuation. Data analysis of semi structured interviews conducted with 20 school principals, revealed a contradiction between the educational ideology that emerged in the context of the overall educational practice and the ideology referred to in the context of their role in teachers professional development. In the context of the educational practice, the majority of principals described an individuation ideology. In the context the principals' role regarding the professional development of the teaching staff, the majority of school principals presented the socialization ideology as their guiding ethos. In addition, the minority of principals demonstrated a combination of these two ideologies. None of the principals presented the acculturation ideology.
- Published
- 2021
34. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
- Author
-
Huerga, Helena, Villalba, Julian, Grandjean, Louis, Sotgiu, Giovanni, Egere, Uzochukwu, Singh, Sarman, Zhu, Limei, Lienhardt, Christian, Denholm, Justin, Seddon, James, Whalen, Christopher, García-Basteiro, Alberto, Triasih, Rina, Chen, Cheng, Singh, Jitendra, Huang, Li-Min, Sharma, Surendra, Hannoun, Djohar, Del Corral, Helena, Mandalakas, Anna, Malone, LaShaunda, Ling, Du-Lin, Kritski, Afrânio, Stein, Catherine, Vashishtha, Richa, Boulahbal, Fadila, Fang, Chi-Tai, Boom, W, Netto, Eduardo, Lemos, Antonio, Hesseling, Anneke, Kay, Alexander, Jones-López, Edward, Horsburgh, C, Lange, Christoph, Andrews, Jason, Martinez, Leonardo, Cords, Olivia, Liu, Qiao, Acuna-Villaorduna, Carlos, Bonnet, Maryline, Fox, Greg, Carvalho, Anna, Chan, Pei-Chun, Croda, Julio, Hill, Philip, Lopez-Varela, Elisa, Donkor, Simon, Fielding, Katherine, Graham, Stephen, Espinal, Marcos, Kampmann, Beate, and Reingold, Arthur
- Subjects
Adolescent ,Adult ,Aged ,BCG Vaccine ,Child ,Child ,Preschool ,Humans ,Infant ,Infant ,Newborn ,Retrospective Studies ,Tuberculosis ,Tuberculosis ,Pulmonary ,Vaccination - Abstract
BACKGROUND: BCG vaccines are given to more than 100 million children every year, but there is considerable debate regarding the effectiveness of BCG vaccination in preventing tuberculosis and death, particularly among older children and adults. We therefore aimed to investigate the age-specific impact of infant BCG vaccination on tuberculosis (pulmonary and extrapulmonary) development and mortality. METHODS: In this systematic review and individual participant data meta-analysis, we searched MEDLINE, Web of Science, BIOSIS, and Embase without language restrictions for case-contact cohort studies of tuberculosis contacts published between Jan 1, 1998, and April 7, 2018. Search terms included mycobacterium tuberculosis, TB, tuberculosis, and contact. We excluded cohort studies that did not provide information on BCG vaccination or were done in countries that did not recommend BCG vaccination at birth. Individual-level participant data for a prespecified list of variables, including the characteristics of the exposed participant (contact), the index case, and the environment, were requested from authors of all eligible studies. Our primary outcome was a composite of prevalent (diagnosed at or within 90 days of baseline) and incident (diagnosed more than 90 days after baseline) tuberculosis in contacts exposed to tuberculosis. Secondary outcomes were pulmonary tuberculosis, extrapulmonary tuberculosis, and mortality. We derived adjusted odds ratios (aORs) using mixed-effects, binary, multivariable logistic regression analyses with study-level random effects, adjusting for the variable of interest, baseline age, sex, previous tuberculosis, and whether data were collected prospectively or retrospectively. We stratified our results by contact age and Mycobacterium tuberculosis infection status. This study is registered with PROSPERO, CRD42020180512. FINDINGS: We identified 14 927 original records from our database searches. We included participant-level data from 26 cohort studies done in 17 countries in our meta-analysis. Among 68 552 participants, 1782 (2·6%) developed tuberculosis (1309 [2·6%] of 49 686 BCG-vaccinated participants vs 473 [2·5%] of 18 866 unvaccinated participants). The overall effectiveness of BCG vaccination against all tuberculosis was 18% (aOR 0·82, 95% CI 0·74-0·91). When stratified by age, BCG vaccination only significantly protected against all tuberculosis in children younger than 5 years (aOR 0·63, 95% CI 0·49-0·81). Among contacts with a positive tuberculin skin test or IFNγ release assay, BCG vaccination significantly protected against tuberculosis among all participants (aOR 0·81, 95% CI 0·69-0·96), participants younger than 5 years (0·68, 0·47-0·97), and participants aged 5-9 years (0·62, 0·38-0·99). There was no protective effect among those with negative tests, unless they were younger than 5 years (0·54, 0·32-0·90). 14 cohorts reported on whether tuberculosis was pulmonary or extrapulmonary (n=57 421). BCG vaccination significantly protected against pulmonary tuberculosis among all participants (916 [2·2%] in 41 119 vaccinated participants vs 334 [2·1%] in 16 161 unvaccinated participants; aOR 0·81, 0·70-0·94) but not against extrapulmonary tuberculosis (106 [0·3%] in 40 318 vaccinated participants vs 38 [0·2%] in 15 865 unvaccinated participants; 0·96, 0·65-1·41). In the four studies with mortality data, BCG vaccination was significantly protective against death (0·25, 0·13-0·49). INTERPRETATION: Our results suggest that BCG vaccination at birth is effective at preventing tuberculosis in young children but is ineffective in adolescents and adults. Immunoprotection therefore needs to be boosted in older populations. FUNDING: National Institutes of Health.
- Published
- 2022
35. Shortage of essential pediatric medications puts children's health at risk. Results from a European Confederation of Primary Care Paediatricians (ECPCP) Survey 2023
- Author
-
Magendie, Christine, Huss, Gottfried, Reali, Laura, and Reingold, Stephen
- Published
- 2024
- Full Text
- View/download PDF
36. Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022
- Author
-
Singson, Jason Robert C, Kirley, Pam Daily, Pham, Huong, Rothrock, Gretchen, Armistead, Isaac, Meek, James, Anderson, Evan J, Reeg, Libby, Lynfield, Ruth, Ropp, Susan, Muse, Alison, Felsen, Christina B, Sutton, Melissa, Talbot, H Keipp, Havers, Fiona P, Taylor, Christopher A, Reingold, Arthur, Chai, Shua J, Alden, Nisha B, Yousey-Hindes, Kim, Openo, Kyle P, Bye, Erica, Montoya, Mark A, Barney, Grant, Popham, Kevin, Abdullah, Nasreen, and Schaffner, William
- Subjects
Prevention ,Good Health and Well Being ,Adolescent ,Adult ,COVID-19 ,COVID-19 Vaccines ,Hospital Mortality ,Hospitalization ,Humans ,Immunocompromised Host ,COVID-NET Surveillance Team ,General & Internal Medicine - Abstract
Immunocompromised persons are at increased risk for severe COVID-19-related outcomes, including intensive care unit (ICU) admission and death (1). Data on adults aged ≥18 years hospitalized with laboratory-confirmed COVID-19 from 10 U.S. states in the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to assess associations between immunocompromise and ICU admission and in-hospital death during March 1, 2020-February 28, 2022. Associations of COVID-19 vaccination status with ICU admission and in-hospital death were also examined during March 1, 2021-February 28, 2022. During March 1, 2020-February 28, 2022, among a sample of 22,345 adults hospitalized for COVID-19, 12.2% were immunocompromised. Among unvaccinated patients, those with immunocompromise had higher odds of ICU admission (adjusted odds ratio [aOR] = 1.26; 95% CI = 1.08-1.49) and in-hospital death (aOR = 1.34; 95% CI = 1.05-1.70) than did nonimmunocompromised patients. Among vaccinated patients,* those with immunocompromise had higher odds of ICU admission (aOR = 1.40; 95% CI = 1.01-1.92) and in-hospital death (aOR = 1.87; 95% CI = 1.28-2.75) than did nonimmunocompromised patients. During March 1, 2021-February 28, 2022, among nonimmunocompromised patients, patients who were vaccinated had lower odds of death (aOR = 0.58; 95% CI = 0.39-0.86) than did unvaccinated patients; among immunocompromised patients, odds of death between vaccinated and unvaccinated patients did not differ. Immunocompromised persons need additional protection from COVID-19 and using multiple known COVID-19 prevention strategies,† including nonpharmaceutical interventions, up-to-date vaccination of immunocompromised persons and their close contacts,§ early testing, and COVID-19 prophylactic (Evusheld) and early antiviral treatment,¶ can help prevent hospitalization and subsequent severe COVID-19 outcomes among immunocompromised persons.
- Published
- 2022
37. Epidemiologic Features of Acute Pediatric Diarrhea in Managua, Nicaragua, from 2011 to 2019
- Author
-
Zambrana, José Victor, Carrillo, Fausto Andres Bustos, Ojeda, Sergio, Mercado, Brenda Lopez, Latta, Krista, Schiller, Amy, Kuan, Guillermina, Gordon, Aubree, Reingold, Arthur, and Harris, Eva
- Subjects
Digestive Diseases ,Pediatric Research Initiative ,Pediatric ,Prevention ,Clinical Research ,Vaccine Related ,Aetiology ,2.4 Surveillance and distribution ,Good Health and Well Being ,Adolescent ,Child ,Child ,Preschool ,Diarrhea ,Family Characteristics ,Humans ,Incidence ,Longitudinal Studies ,Nicaragua ,Prospective Studies ,Seasons ,Medical and Health Sciences ,Tropical Medicine - Abstract
Diarrhea remains a leading cause of death in children in developing countries, including Nicaragua, but little is known about patterns of diarrhea occurrence in Central America over long periods of time. The purpose of this study was to determine the incidence, risk factors, long-term trends, and seasonality of diarrhea in children age 2 to 14 years in Managua, Nicaragua. From 2011 to 2019, we examined episodes of diarrhea among 6,485 children who participated in a prospective cohort study and presented for care in a primary care facility. We performed a longitudinal analysis considering time-varying variables and the intra-subject correlation of outcomes. In addition, we analyzed the weekly incidence of diarrhea, applying seasonal trend decomposition to extract secular and seasonal patterns. The overall incidence rate of diarrhea was 133.4 episodes per 1,000 person-years (95% CI, 128.3-138.7). We observed a slight increase in the incidence of diarrhea from 2011 to 2019. Younger age was the strongest predictor of the risk of diarrhea, and incidence increased with every additional hour without running water in the household per day. Diarrhea incidence in Managua was seasonal, with high peaks each year between May and July. Despite reductions in childhood mortality since 1990 in Nicaragua, diarrheal morbidity remains a major problem in Managua.
- Published
- 2022
38. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease Among Adults With HIV—United States, 2008–2018
- Author
-
Kobayashi, Miwako, Matanock, Almea, Xing, Wei, Adih, William K, Li, Jianmin, Gierke, Ryan, Almendares, Olivia, Reingold, Arthur, Alden, Nisha, Petit, Susan, Farley, Monica M, Harrison, Lee H, Holtzman, Corinne, Baumbach, Joan, Thomas, Ann, Schaffner, William, McGee, Lesley, and Pilishvili, Tamara
- Subjects
Infectious Diseases ,Clinical Research ,Immunization ,Prevention ,Lung ,Vaccine Related ,Infection ,Good Health and Well Being ,Adult ,Child ,HIV Infections ,Humans ,Incidence ,Infant ,Middle Aged ,Pneumococcal Infections ,Pneumococcal Vaccines ,Serogroup ,United States ,Vaccines ,Conjugate ,Young Adult ,13-valent pneumococcal conjugate vaccine ,invasive pneumococcal disease ,indirect effects ,direct effects ,HIV infection ,Clinical Sciences ,Public Health and Health Services ,Virology - Abstract
BackgroundPeople with HIV (PWH) are at increased risk for invasive pneumococcal disease (IPD). Thirteen-valent pneumococcal conjugate vaccine (PCV13) was recommended for use in US children in 2010 and for PWH aged 19 years or older in 2012. We evaluated the population-level impact of PCV13 on IPD among PWH and non-PWH aged 19 years or older.MethodsWe identified IPD cases from 2008 to 2018 through the Active Bacterial Core surveillance platform. We estimated IPD incidence using the National HIV Surveillance System and US Census Bureau data. We measured percent changes in IPD incidence from 2008 to 2009 to 2017-2018 by HIV status, age group, and vaccine serotype group, including serotypes in recently licensed 15-valent (PCV15) and 20-valent (PCV20) PCVs.ResultsIn 2008-2009 and 2017-2018, 8.4% (552/6548) and 8.0% (416/5169) of adult IPD cases were among PWH, respectively. Compared with non-PWH, a larger proportion of IPD cases among PWH were in adults aged 19-64 years (94.7%-97.4% vs. 56.0%-60.1%) and non-Hispanic Black people (62.5%-73.0% vs. 16.7%-19.2%). Overall and PCV13-type IPD incidence in PWH declined by 40.3% (95% confidence interval: -47.7 to -32.3) and 72.5% (95% confidence interval: -78.8 to -65.6), respectively. In 2017-2018, IPD incidence was 16.8 (overall) and 12.6 (PCV13 type) times higher in PWH compared with non-PWH; PCV13, PCV15/non-PCV13, and PCV20/non-PCV15 serotypes comprised 21.5%, 11.2%, and 16.5% of IPD in PWH, respectively.ConclusionsDespite reductions post-PCV13 introduction, IPD incidence among PWH remained substantially higher than among non-PWH. Higher-valent PCVs provide opportunities to reduce remaining IPD burden in PWH.
- Published
- 2022
39. Policy : The Times They Are A-Changin’ (Finally!)
- Author
-
Reingold, Daniel
- Published
- 2022
40. U. S. Patent Office Records as Sources for the History of Invention and Technological Property
- Author
-
Reingold, Nathan
- Published
- 2023
41. Alexander Dallas Bache: Science and Technology in the American Idiom
- Author
-
Reingold, Nathan
- Published
- 2023
42. Introduction
- Author
-
Reingold, Nathan and Molella, Arthur
- Published
- 2023
43. Increased fracture risk among children diagnosed with attention- deficit/hyperactivity disorder: a large matched cohort study
- Author
-
Ziv-Baran, Tomer, Zacay, Galia, Modan-Moses, Dalit, Reingold, Stephen M., Mekori, Ehud, and Levy-Shraga, Yael
- Published
- 2023
- Full Text
- View/download PDF
44. Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017.
- Author
-
Kujawski, Stephanie, Whitaker, Michael, Ritchey, Matthew, Chai, Shua, Anderson, Evan, Openo, Kyle, Monroe, Maya, Ryan, Patricia, Bye, Erica, Como-Sabetti, Kathryn, Barney, Grant, Muse, Alison, Bennett, Nancy, Felsen, Christina, Thomas, Ann, Crawford, Courtney, Talbot, H, Schaffner, William, Gerber, Susan, Langley, Gayle, Kim, Lindsay, and Reingold, Arthur
- Subjects
Adult ,Aged ,Heart Failure ,Hospitalization ,Humans ,Infant ,Influenza ,Human ,Respiratory Syncytial Virus Infections ,Respiratory Syncytial Virus ,Human ,United States - Abstract
BACKGROUND: Respiratory syncytial virus (RSV) can cause severe disease in adults with cardiopulmonary conditions, such as congestive heart failure (CHF). We quantified the rate of RSV-associated hospitalization in adults by CHF status using population-based surveillance in the United States. METHODS: Population-based surveillance for RSV (RSV-NET) was performed in 35 counties in seven sites during two respiratory seasons (2015-2017) from October 1-April 30. Adults (≥18 years) admitted to a hospital within the surveillance catchment area with laboratory-confirmed RSV identified by clinician-directed testing were included. Presence of underlying CHF was determined by medical chart abstraction. We calculated overall and age-stratified (
- Published
- 2022
45. Risky business: A mixed methods study of decision-making regarding COVID-19 risk at a public university in the United States
- Author
-
Facente, Shelley N, De Zuzuarregui, Mariah, Frank, Darren, Gomez-Aladino, Sarah, Muñoz, Ariel, Williamson, Sabrina, Wang, Emily, Hunter, Lauren, Packel, Laura, Reingold, Arthur, and Petersen, Maya
- Subjects
Biomedical and Clinical Sciences ,Psychology ,Basic Behavioral and Social Science ,Emerging Infectious Diseases ,Behavioral and Social Science ,Clinical Research ,Patient Safety ,Prevention ,Good Health and Well Being ,COVID-19 ,risk ,qualitative ,risk behaviors ,students ,Cognitive Sciences ,Biomedical and clinical sciences - Abstract
IntroductionUntil vaccines became available in late 2020, our ability to prevent the spread of COVID-19 within countries depended largely on voluntary adherence to mitigation measures. However, individual decision-making regarding acceptable COVID-19 risk is complex. To better understand decision-making regarding COVID-19 risk, we conducted a qualitative substudy within a larger Berkeley COVID-19 Safe Campus Initiative (BCSCI) during the summer of 2020, and completed a mixed-methods analysis of factors influencing decision-making.Materials and methodsWe interviewed 20 participants who tested positive for SARS-CoV-2 and 10 who remained negative, and analyzed quantitative survey data from 3,324 BCSCI participants. The BCSCI study enrolled university-affiliated people living in the local area during summer of 2020, collected data on behaviors and attitudes toward COVID-19, and conducted SARS-CoV-2 testing at baseline and endline.ResultsAt baseline, 1362 students (57.5%) and 285 non-students (35.1%) said it had been somewhat or very difficult to comply with COVID-19-related mandates. Most-cited reasons were the need to go out for food/essentials, difficulty of being away from family/friends, and loneliness. Eight interviewees explicitly noted they made decisions partially because of others who may be at high risk. We did not find significant differences between the behaviors of students and non-students.DiscussionDespite prevailing attitudes about irresponsibility of college students during the COVID-19 pandemic, students in our study demonstrated a commitment to making rational choices about risk behavior, not unlike non-students around them. Decision-making was driven by perceived susceptibility to severe disease, need for social interaction, and concern about risk to others. A harm reduction public health approach may be beneficial.
- Published
- 2022
46. Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022
- Author
-
Havers, Fiona P, Patel, Kadam, Whitaker, Michael, Milucky, Jennifer, Reingold, Arthur, Armistead, Isaac, Meek, James, Anderson, Evan J, Weigel, Andy, Reeg, Libby, Seys, Scott, Ropp, Susan L, Spina, Nancy, Felsen, Christina B, Moran, Nancy E, Sutton, Melissa, Talbot, H Keipp, George, Andrea, Taylor, Christopher A, Daily Kirley, Pam, Alden, Nisha B, Yousey-Hindes, Kimberly, Openo, Kyle P, Brown, Chloe, Schardin, Cody T, Plymesser, Kelly, Barney, Grant, Popham, Kevin, Billing, Laurie M, Abdullah, Nasreen, Markus, Tiffanie M, and Hill, Mary
- Subjects
Clinical Research ,Infectious Diseases ,Vaccine Related ,Prevention ,Good Health and Well Being ,Adolescent ,Adult ,COVID-19 ,COVID-19 Vaccines ,Hospitalization ,Humans ,SARS-CoV-2 ,United States ,Vaccination ,COVID-NET Surveillance Team ,General & Internal Medicine - Abstract
Beginning the week of March 20–26, 2022, the Omicron BA.2 variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating variant in the United States, accounting for >50% of sequenced isolates.* Data from the COVID-19–Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to describe recent COVID-19–associated hospitalization rates among adults aged ≥18 years during the period coinciding with BA.2 predominance (BA.2 period [Omicron BA.2 and BA.2.12.1; March 20–May 31, 2022]). Weekly hospitalization rates (hospitalizations per 100,000 population) among adults aged ≥65 years increased threefold, from 6.9 (week ending April 2, 2022) to 27.6 (week ending May 28, 2022); hospitalization rates in adults aged 18–49 and 50–64 years both increased 1.7-fold during the same time interval. Hospitalization rates among unvaccinated adults were 3.4 times as high as those among vaccinated adults. Among hospitalized nonpregnant patients in this same period, 39.1% had received a primary vaccination series and 1 booster or additional dose; 5.0% had received a primary series and ≥2 boosters or additional doses. All adults should stay up to date† with COVID-19 vaccination, and multiple nonpharmaceutical and medical prevention measures should be used to protect those at high risk for severe COVID-19 illness, irrespective of vaccination status§ (1).Beginning the week of March 20–26, 2022, the Omicron BA.2 variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating variant in the United States, accounting for >50% of sequenced isolates.* Data from the COVID-19–Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to describe recent COVID-19–associated hospitalization rates among adults aged ≥18 years during the period coinciding with BA.2 predominance (BA.2 period [Omicron BA.2 and BA.2.12.1; March 20–May 31, 2022]). Weekly hospitalization rates (hospitalizations per 100,000 population) among adults aged ≥65 years increased threefold, from 6.9 (week ending April 2, 2022) to 27.6 (week ending May 28, 2022); hospitalization rates in adults aged 18–49 and 50–64 years both increased 1.7-fold during the same time interval. Hospitalization rates among unvaccinated adults were 3.4 times as high as those among vaccinated adults. Among hospitalized nonpregnant patients in this same period, 39.1% had received a primary vaccination series and 1 booster or additional dose; 5.0% had received a primary series and ≥2 boosters or additional doses. All adults should stay up to date† with COVID-19 vaccination, and multiple nonpharmaceutical and medical prevention measures should be used to protect those at high risk for severe COVID-19 illness, irrespective of vaccination status§ (1).
- Published
- 2022
47. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.
- Author
-
Nguyen, Anna T, Arnold, Benjamin F, Kennedy, Chris J, Mishra, Kunal, Pokpongkiat, Nolan N, Seth, Anmol, Djajadi, Stephanie, Holbrook, Kate, Pan, Erica, Kirley, Pam D, Libby, Tanya, Hubbard, Alan E, Reingold, Arthur, Colford, John M, and Benjamin-Chung, Jade
- Subjects
Humans ,Influenza Vaccines ,Vaccination ,Cohort Studies ,Cross-Sectional Studies ,Schools ,Aged ,Child ,School Health Services ,California ,Influenza ,Human ,Ethnicity ,Vaccine Efficacy ,Hospitalizations ,Influenza ,School-located influenza vaccinations ,Vaccination coverage ,Vaccinations ,Immunization ,Clinical Research ,Pneumonia & Influenza ,Vaccine Related ,Emerging Infectious Diseases ,Prevention ,Biological Sciences ,Agricultural and Veterinary Sciences ,Medical and Health Sciences ,Virology - Abstract
BackgroundIncreasing influenza vaccination coverage in school-aged children may substantially reduce community transmission. School-located influenza vaccinations (SLIV) aim to promote vaccinations by increasing accessibility, which may be especially beneficial to race/ethnicity groups that face high barriers to preventative care. Here, we evaluate the effectiveness of a city-wide SLIV program by race/ethnicity from 2014 to 2018.MethodsWe used multivariate matching to pair schools in the intervention district in Oakland, CA with schools in a comparison district in West Contra Costa County, CA. We distributed cross-sectional surveys to measure caregiver-reported student vaccination status and estimated differences in vaccination coverage levels and reasons for non-vaccination between districts stratifying by race/ethnicity. We estimated difference-in-differences (DID) of laboratory confirmed influenza hospitalization incidence between districts stratified by race/ethnicity using surveillance data.ResultsDifferences in influenza vaccination coverage in the intervention vs. comparison district were larger among White (2017-18: 21.0% difference [95% CI: 9.7%, 32.3%]) and Hispanic/Latino (13.4% [8.8%, 18.0%]) students than Asian/Pacific Islander (API) (8.9% [1.3%, 16.5%]), Black (5.9% [-2.2%, 14.0%]), and multiracial (6.3% [-1.8%, 14.3%)) students. Concerns about vaccine effectiveness or safety were more common among Black and multiracial caregivers. Logistical barriers were less common in the intervention vs. comparison district, with the largest difference among White students. In both districts, hospitalizations in 2017-18 were higher in Blacks (Intervention: 111.5 hospitalizations per 100,00; Comparison: 134.1 per 100,000) vs. other races/ethnicities. All-age influenza hospitalization incidence was lower in the intervention site vs. comparison site among White/API individuals in 2016-17 (DID -25.14 per 100,000 [95% CI: -40.14, -10.14]) and 2017-18 (-36.6 per 100,000 [-52.7, -20.5]) and Black older adults in 2017-18 (-282.2 per 100,000 (-508.4, -56.1]), but not in other groups.ConclusionsSLIV was associated with higher vaccination coverage and lower influenza hospitalization, but associations varied by race/ethnicity. SLIV alone may be insufficient to ensure equitable influenza outcomes.
- Published
- 2022
48. Measles in conflict-affected northern Syria: results from an ongoing outbreak surveillance program
- Author
-
Mehtar, Sammy, AlMhawish, Naser, Shobak, Kasim, Reingold, Art, Guha-Sapir, Debarati, and Haar, Rohini J
- Subjects
Vaccine Related ,Clinical Research ,Emerging Infectious Diseases ,Infectious Diseases ,Infection ,Good Health and Well Being ,Syria ,Conflict ,War ,Measles ,Epidemic ,Infectious diseases ,Surveillance ,Vaccine ,Vaccine-preventable disease ,Public Health and Health Services - Abstract
BackgroundThe Syrian conflict has dramatically changed the public health landscape of Syria since its onset in March of 2011. Depleted resources, fractured health systems, and increased security risks have disrupted many routine services, including vaccinations, across several regions in Syria. Improving our understanding of infectious disease transmission in conflict-affected communities is imperative, particularly in the Syrian conflict. We utilize surveillance data from the Early Warning Alert and Response Network (EWARN) database managed by the Assistance Coordination Unit (ACU) to explore trends in the incidence of measles in conflict-affected northern Syria and analyze two consecutive epidemics in 2017 and 2018.MethodsWe conducted a retrospective time-series analysis of the incidence of clinically suspected cases of measles using EWARN data between January 2015 and June 2019. We compared regional and temporal trends to assess differences between geographic areas and across time.ResultsBetween January 2015 and June 2019, there were 30,241 clinically suspected cases of measles reported, compared to 3193 cases reported across the whole country in the decade leading up to the conflict. There were 960 regional events that met the measles outbreak threshold and significant differences in the medians of measles incidence across all years (p-value
- Published
- 2021
49. Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States
- Author
-
Dorjee, Kunchok, Desai, Manisha, Choden, Tsering, Baxi, Sanjiv M, Hubbard, Alan E, and Reingold, Arthur L
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,HIV/AIDS ,Heart Disease ,Cardiovascular ,Heart Disease - Coronary Heart Disease ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Anti-HIV Agents ,Dideoxynucleosides ,Drug Combinations ,HIV Infections ,HIV-1 ,Humans ,Lamivudine ,Myocardial Infarction ,Tenofovir ,United States ,Human Immunodeficiency Virus ,Antiretroviral agents ,Cardiovascular disease ,Immunology ,Virology ,Clinical sciences - Abstract
IntroductionAlthough individual antiretroviral drugs have been shown to be associated with elevated cardiovascular disease (CVD) risk, data are limited on the role of antiretroviral drug combinations. Therefore, we sought to investigate CVD risk associated with antiretroviral drug combinations.MethodsUsing an administrative health-plan dataset, risk of acute myocardial infarction (AMI) associated with current exposure to antiretroviral drug combinations was assessed among persons living with HIV receiving antiretroviral therapy (ART) across the U.S. from October 2009 through December 2014. To account for confounding-by-indication and for factors simultaneously acting as causal mediators and confounders, we applied inverse probability of treatment weighted marginal structural models to longitudinal data of patients.ResultsOver 114,417 person-years (n = 73,071 persons) of ART exposure, 602 cases of AMI occurred at an event rate of 5.26 (95% CI: 4.86, 5.70)/1000 person-years. Of the 14 antiretroviral drug combinations studied, persons taking abacavir-lamivudine-darunavir had the highest incidence rate (IR: 11/1000; 95% CI: 7.4-16.0) of AMI. Risk (HR; 95% CI) of AMI was elevated for current exposure to abacavir-lamivudine-darunavir (1.91; 1.27-2.88), abacavir-lamivudine-atazanavir (1.58; 1.08-2.31), and tenofovir-emtricitabine-raltegravir (1.35; 1.07-1.71). Tenofovir-emtricitabine-efavirenz was associated with reduced risk (0.65; 0.54-0.78). Abacavir-lamivudine-darunavir was associated with increased risk of AMI beyond that expected of abacavir alone, likely attributable to darunavir co-administration. We did not find an elevated risk of AMI when abacavir-lamivudine was combined with efavirenz or raltegravir.ConclusionThe antiretroviral drug combinations abacavir-lamivudine-darunavir, abacavir-lamivudine-atazanavir and tenofovir-emtricitabine-raltegravir were found to be associated with elevated risk of AMI, while tenofovir-emtricitabine-efavirenz was associated with a lower risk. The AMI risk associated with abacavir-lamivudine-darunavir was greater than what was previously described for abacavir, which could suggest an added risk from darunavir. The results should be confirmed in additional studies.
- Published
- 2021
50. Feasibility and effectiveness of daily temperature screening to detect COVID-19 in a prospective cohort at a large public university
- Author
-
Facente, Shelley N, Hunter, Lauren A, Packel, Laura J, Li, Yi, Harte, Anna, Nicolette, Guy, McDevitt, Shana, Petersen, Maya, and Reingold, Arthur L
- Subjects
Vaccine Related ,Biodefense ,Infectious Diseases ,Clinical Research ,Prevention ,Emerging Infectious Diseases ,Infection ,Good Health and Well Being ,COVID-19 ,Feasibility Studies ,Humans ,Prospective Studies ,SARS-CoV-2 ,Temperature ,Universities ,Fever ,Temperature monitoring ,Thermometer ,Detection ,Screening ,Public Health and Health Services ,Public Health - Abstract
BackgroundMany persons with active SARS-CoV-2 infection experience mild or no symptoms, presenting barriers to COVID-19 prevention. Regular temperature screening is nonetheless used in some settings, including university campuses, to reduce transmission potential. We evaluated the potential impact of this strategy using a prospective university-affiliated cohort.MethodsBetween June and August 2020, 2912 participants were enrolled and tested for SARS-CoV-2 by PCR at least once (median: 3, range: 1-9). Participants reported temperature and symptoms daily via electronic survey using a previously owned or study-provided thermometer. We assessed feasibility and acceptability of daily temperature monitoring, calculated sensitivity and specificity of various fever-based strategies for restricting campus access to reduce transmission, and estimated the association between measured temperature and SARS-CoV-2 test positivity using a longitudinal binomial mixed model.ResultsMost participants (70.2%) did not initially have a thermometer for taking their temperature daily. Across 5481 total person months, the average daily completion rate of temperature values was 61.6% (median: 67.6%, IQR: 41.8-86.2%). Sensitivity for SARS-CoV-2 ranged from 0% (95% CI 0-9.7%) to 40.5% (95% CI 25.6-56.7%) across all strategies for self-report of possible COVID-19 symptoms on day of specimen collection, with corresponding specificity of 99.9% (95% CI 99.8-100%) to 95.3% (95% CI 94.7-95.9%). An increase of 0.1 °F in individual mean body temperature on the same day as specimen collection was associated with 1.11 increased odds of SARS-CoV-2 positivity (95% CI 1.06-1.17).ConclusionsOur study is the first, to our knowledge, that examines the feasibility, acceptability, and effectiveness of daily temperature screening in a prospective cohort during an infectious disease outbreak, and the only study to assess these strategies in a university population. Daily temperature monitoring was feasible and acceptable; however, the majority of potentially infectious individuals were not detected by temperature monitoring, suggesting that temperature screening is insufficient as a primary means of detection to reduce transmission of SARS-CoV-2.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.